CG Oncology (CGON) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for CG Oncology, as the data feed reports them.

Analysts' mean target, 13 analysts
$106.15
34.5% above the price

The 13 analysts reported by the data feed have a mean price target for CG Oncology of $106.15, 34.5% above the $78.94 price (range $87.00–$150.00). 10.50% of the float was sold short as of Oct 30, 2026. Institutions hold 111.7% of the shares and insiders 0.2%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$106.15+34.5% vs price
Analysts
13
Short interest
10.50%of float, Oct 30, 2026
Short ratio
10.08 days
Institutions
111.7%
Insiders
0.23%
Beta
0.35

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

13 analysts covering CG Oncology, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $78.94.

Analysts' price targets for CG Oncology
Mean price target$106.1534.5% above the price (+34.5%)
Median price target$102.0029.2% above the price (+29.2%)
Highest target$150.0090.0% above the price (+90.0%)
Lowest target$87.0010.2% above the price (+10.2%)
Analysts with a target13

Ratings this month · 14 analysts

Strong buy 3(21%)Buy 10(71%)Hold 1(7%)
Analysts' ratings of CG Oncology this month, by rating
RatingAnalystsShare
Strong buy321%
Buy1071%
Hold17%
Sell00%
Strong sell00%

The feed averages these to 1.29 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns CG Oncology

Ownership of CG Oncology
Held by institutions111.7%341 institutions; percent of shares outstanding
Held by institutions, of the float111.9%
Held by insiders0.23%percent of shares outstanding
Shares outstanding89.32M
Float68.95Mshares available to trade
Insiders' net purchases, six months+371.09K10 purchases (412.21K shares), 9 sales (41.13K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in CG Oncology
Shares short9.22Mas of Oct 30, 2026
Percent of float10.50%shares short ÷ float
Percent of shares outstanding10.32%shares short ÷ shares outstanding
Short ratio (days to cover)10.08shares short ÷ average daily volume

CG Oncology short interest from FINRA, with its history

Trading figures

Trading figures for CG Oncology
Beta0.35movement against the market; 1 moves with it
52-week high$93.95
52-week low$37.01
Average volume, 3 months1.14Mshares a day
Average volume, 10 days2.44Mshares a day

Questions and answers

What is the analysts' price target for CG Oncology (CGON)?

As reported by the data feed, the mean price target of the 13 analysts covering CG Oncology is $106.15, 34.5% above the latest price of $78.94. The highest target is $150.00 and the lowest $87.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate CG Oncology stock?

Of the 14 ratings the data feed reports for the current month, 3 are strong buy, 10 buy, 1 hold, 0 sell and 0 strong sell.

How many CG Oncology shares are sold short?

As reported by the data feed, 9.22M shares were sold short, 10.50% of the float as of Oct 30, 2026. At the average daily volume that is 10.08 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns CG Oncology stock?

As reported by the data feed, institutions hold 111.7% of the shares (341 institutions) and insiders 0.2%. There are 89.32M shares outstanding, of which 68.95M are in the float.

How much does CG Oncology stock move with the market?

Its beta, as reported by the data feed, is 0.35: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $37.01 and $93.95.

Cite this page

Funkfolio, “CG Oncology (CGON) statistics: analyst targets and short interest”, data as of 17 November 2026. https://funkfolio.com/stock/CGON/statistics

Underlying data: Yahoo Finance.